Advance in Therapeutic Targets of Intrahepatic Cholangiocarcinoma

LIN Jian; WANG Haibo; SHEN Feng

doi:10.3971/j.issn.1000-8578.2021.20.1248

LIN Jian, WANG Haibo, SHEN Feng. Advance in Therapeutic Targets of Intrahepatic Cholangiocarcinoma[J]. Cancer Research on Prevention and Treatment, 2021, 48(3): 224-228. DOI: 10.3971/j.issn.1000-8578.2021.20.1248

Citation:

LIN Jian, WANG Haibo, SHEN Feng. Advance in Therapeutic Targets of Intrahepatic Cholangiocarcinoma[J]. Cancer Research on Prevention and Treatment, 2021, 48(3): 224-228. DOI: 10.3971/j.issn.1000-8578.2021.20.1248

Citation:

LIN Jian, WANG Haibo, SHEN Feng. Advance in Therapeutic Targets of Intrahepatic Cholangiocarcinoma[J]. Cancer Research on Prevention and Treatment, 2021, 48(3): 224-228. DOI: 10.3971/j.issn.1000-8578.2021.20.1248

Advance in Therapeutic Targets of Intrahepatic Cholangiocarcinoma

Abstract

Abstract

Intrahepatic cholangiocarcinoma (ICC) is highly invasive and has poor prognosis. At present, there is no effective adjuvant treatment. With the indepth researches on ICC-related tumor microenvironment, gene, protein, epigenetic modification and signaling pathway, the potential therapeutic targets have been found. This article will review the novel potential therapeutic targets of ICC.

FullText(HTML)

References (37)

Advance in Therapeutic Targets of Intrahepatic Cholangiocarcinoma

Abstract

Catalog

Export File

Citation

Format

Content